Arthritis after jejunoileostomy for intractable obesity.
Joint symptoms developed in six of 33 patients (18%) who had jejunoileostomy as treatment for intractable obesity. These consisted of single or recurrent attacks of polyarthritis or arthralgias, primarily in large joints. The histocompatibility antigen, HL-A B27, was not present in these patients. Most attacks responded to simple analgesic agents, but a trial of tetracycline in one patient failed to relieve joint symptoms. This arthropathy seems to differ from that which has been reported after jejunocolostomy.
D000328:Adult; D001168:Arthritis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D005260:Female; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007421:Intestine, Small / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000628:therapy*; D010653:Phenylbutazone / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D006680:HLA Antigens; D013752:Tetracycline; D010653:Phenylbutazone; D007213:Indomethacin